Caregen Co. Ltd.
Quick facts
Marketed products
- Aflibercept Injection [Eylea] · Ophthalmology
Aflibercept is a soluble decoy receptor that binds and neutralizes vascular endothelial growth factor (VEGF) and placental growth factor (PlGF), inhibiting their signaling to reduce abnormal blood vessel growth and vascular permeability in the eye.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Caregen Co. Ltd.
What are Caregen Co. Ltd.'s marketed drugs?
Top marketed products include Aflibercept Injection [Eylea].
Related
- Aflibercept Injection [Eylea] · Ophthalmology
- Sector hub: All tracked pharma companies